Positive effect of dietary soy in ESRD patients with systemic inflammation—correlation between blood levels of the soy isoflavones and the acute-phase reactants | Zendy

Paolo Fanti | Zendy; Reto Asmis | Zendy; Tammy Stephenson | Zendy; B. Peter Sawaya | Zendy; Adrian A. Franke | Zendy

Open Access

Positive effect of dietary soy in ESRD patients with systemic inflammation—correlation between blood levels of the soy isoflavones and the acute-phase reactants

Author(s) -

Paolo Fanti,

Reto Asmis,

Tammy Stephenson,

B. Peter Sawaya,

Adrian A. Franke

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl169

Subject(s) - medicine , isoflavones , genistein , soy protein , systemic inflammation , hemodialysis , c reactive protein , inflammation , gastroenterology , kidney disease , soy isoflavones , endocrinology , pathology

Inflammation is commonly associated with malnutrition and cardiovascular disease in end-stage renal failure patients. Anti-inflammatory properties of the isoflavones, a micronutrient component of soy, have been reported in several experimental models and disease conditions, but never in renal failure. We hypothesized that dietary soy isoflavones correct laboratory evidence of systemic inflammation in haemodialysis (HD) patients with underlying high blood levels of C-reactive protein (CRP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research